Intervention

Modified Vaccinia Virus Ankara Vaccine Expressing p53

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions17

Lead sponsors shown1

Clinical trials

1 shown

Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior TherapyNCT02432963 · 2016-06-14

ACTIVE_NOT_RECRUITING

Common conditions

Adult Solid Neoplasm1 Bladder Carcinoma1 Colon Carcinoma1 Estrogen Receptor Negative1 Head and Neck Squamous Cell Carcinoma1 Hepatocellular Carcinoma1 HER2/Neu Negative1 Melanoma1 Non-Small Cell Lung Carcinoma1 Pancreatic Carcinoma1 Progesterone Receptor Negative1 Rectal Carcinoma1 Renal Cell Carcinoma1 Soft Tissue Sarcoma1 TP53 Gene Mutation1 Triple-Negative Breast Carcinoma1 Unresectable Solid Neoplasm1

Leading sponsors

City of Hope Medical Center1

Trial status mix

ACTIVE_NOT_RECRUITING1

Phase mix

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.